ezetimibe genoptim 10 mg tabletki
synoptis pharma sp. z o.o. - ezetimibum - tabletki - 10 mg
gastrocynesine - tabletki
boiron sa - abies nigra 4ch + carbo vegetabilis + robinia pseudo-acacia 4ch + nux vomica - tabletki - -
carbo vegetabilis 3ch, 4ch, 5ch, 7ch, 9ch, 12ch, 15ch, 30ch, 200ch, 6k, 12k, 30k, 200k, 1mk, 10mk, 100mk granulki; granulki w pojemniku jednodawkowym; krople doustne, roztwór
boiron sa - granulki; granulki w pojemniku jednodawkowym; krople doustne, roztwór - 3ch, 4ch, 5ch, 7ch, 9ch, 12ch, 15ch, 30ch, 200ch, 6k, 12k, 30k, 200k, 1mk, 10mk, 100mk
gastricumeel - tabletki
biologische heilmittel heel gmbh - tabletki - -
dr reckeweg r5 - krople doustne, roztwór
pharmazeutische fabrik dr reckeweg & co gmbh - carbo vegetabilis + ethanolum + lycopodium clavatum + chamomilla recutita + semecarpus anacardium d6 + atropa belladonna d1 - krople doustne, roztwór - -
leptandra compositum krople doustne, roztwór
biologische heilmittel heel gmbh - acidum arsenicosum; carbo vegetabilis; phosphorus; picrasma excelsa; podophyllum peltatum d4; niccolum metallicum; veronica virginica - krople doustne, roztwór
voxpax - tabletka
laboratoires lehning - pimpinella anisum + olibanum + arum triphyllum + carbo vegetabilis + hepar sulfuris + mangani peroxydatum + arsenicum album + sisymbrium officinalis - tabletka - -
rosuvastatin medical valley 5 mg tabletki powlekane
medical valley invest ab - rosuvastatin calcium - tabletki powlekane - 5 mg
celsentri
viiv healthcare b.v. - marawirok - infekcje hiv - Środki przeciwwirusowe do użytku ogólnoustrojowego - celsentri, in combination with other antiretroviral medicinal products, is indicated for treatment experienced adults, adolescents and children of 2 years of age and older and weighing at least 10 kg infected with only ccr5-tropic hiv-1 detectable,.
thyrogen
sanofi b.v. - tyreotropina alfa - nowotwory tarczycy - przedniego płata przysadki hormony i analogi, przysadkę mózgową i podwzgórze hormony i odpowiedniki - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.